Univasc

Active Ingredient(s): Moexipril
FDA Approved: * April 19, 1995
Pharm Company: * SCHWARZ PHARMA
Category: Blood Pressure

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Univasc Overview

Moexipril an angiotensin converting enzyme inhibitor (ACE inhibitor)[1] used for the treatment of hypertension and congestive heart failure. Moexipril can be administered alone or with other antihypertensives or diuretics.[2] It works by inhibiting the conversion of angiotensin I to angiotensin II.[3] It was patented in 1980 and approved for medical use in 1995.[4] Moexipril is available from Schwarz Pharma under the trade name...

Read more Univasc Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Moexipril

Recent Univasc Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Univasc: (2 results)

Sorted by National Drug Code

• 0091-3707 Univasc 7.5 mg Oral Tablet by Ucb, Inc.
• 0091-3715 Univasc 15 mg Oral Tablet by Ucb, Inc.

Other drugs which contain Moexipril or a similar ingredient: (3 results)

• MOEXIPRIL 1 discussion
• HYDROCHLOROTHIAZIDE, HCTZ + MOEXIPRIL
• UNIRETIC Hydrochlorothiazide, HCTZ + Moexipril2 discussions